A biosimilar for Tecfidera, used to treat multiple sclerosis, should launch 3Q2020 with the potential to impact annual sales of $3.5M. Total trend could rise slightly, reflecting higher drug prices, as insulins are considered biologics from March 2020. Changing DIR fee structure. do not make investment recommendations, on this website or otherwise. High investment therapies have stretched current reimbursement models beyond their capacity. Cigna’s Embarc Benefit Protection: Luxterna (Retinal Disorder) and Zolgensma (Spinal Muscular Atrophy), Anthem’s Gene Therapy Solutions: Roctavian (Hemophilia-A). Health plan sponsors are rightly concerned about the possibility that their medical costs could skyrocket if a few of their members started treatment. Here’s a look at eight trends that experts expect will shape the industry next year: Continued shift to value-based care. Specialty drugs are used for the treatment of complex, chronic, or rare conditions such as cancers and hepatitis C. IQVIA’s Medicine Use and Spending Report calculated that per capita drug spending on specialty drugs increased by 55% from 2013-2016. Cancer (oral) and autoimmune treatments were the most influential drug categories in driving higher trend for all lines of business with trends in the double digits. It would not address short term budget issues but would prevent hospitals from marking drug costs up significantly and avoid issues with DRG payments. Pembroke Consulting, Inc., and. Collaboration between payers, providers and manufacturers is possible, and most likely the best strategy to ensure cost effective access to quality care. In 2019, the FDA approved 54 specialty drugs, 31 of which the FDA considered new molecular entities. Zolgensma, (Novartis), approved to treat a rare spinal defect, is the highest cost gene therapy currently at $2M per patient. This has been noted in national surveys on specialty drug cost trends by the National Employer Initiative on Specialty Pharmacy, led by the ... Planning a Specialty Drug Strategy Through 2020 . 2019. ... Growth of specialty market (2015-2020) THE SHIFTING LANDSCAPE CERTARA TRENDS BRIEF 5 US specialty drug spending saw … Diagnosis and Treatment of IBS. THE SHIFTING LANDSCAPE ACCESS TRENDS IN SPECIALTY PHARMACY 2020-23 7 US specialty drug spending saw a modest annual growth of 3%, from 44.7% in 2018 to 47.7% in 2019 per ESI.10 On the basis of non-discounted spending, specialty growth has been outpacing traditional product growth, with a 10% to 0.3% dollar volume increase, per IQVIA. The first biosimilar was launched in the U.S. in 2015. See below a snapshot of specialt… 1 2020 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. ... 2020 Trends in Pharmacy Care: Technology. Here are six developments we believe are worth watching and the ways that action today can help people and communities across the United States on their path to better health. Specialty drugs currently represent 39 percent of the overall pharmacy benefit spend but are projected to grow to 48 percent by 2020. Significant advancements will bring curative therapies to many individuals suffering from rare hereditary diseases. Direct and indirect remuneration (DIR) fees are not going away in 2020 and, in fact, we expect them to grow. Specialty drugs are developed mostly for chronic and degenerative diseases like rheumatoid arthritis, cancer and multiple sclerosis. 4 Smaller, independent SPs are declining, representing 47% of accredited SPs in 2018, compared to 59% in 2015. increasingly innovative strategies. An estimated 7000 rare diseases exist, yet only 500 have FDA approved treatment options, providing only 7% of patients access to pharmaceutical therapy. Novartis has agreed to annuity payments for Zolgensma over five years. The new research report titles Global Specialty Pharmacy Services market Growth 2020-2025 that studies all the vital factors related to the Global Specialty Pharmacy Services market that are crucial for the growth and development of businesses in the given market parameters.The report highlights the important elements related to the market such as the market size, share, company … Is projected to reach $ 600B in 2020, and emerging therapies inherent in the specialty pharmacy marketplace forecast! Should level off in 2020 handling, storage, and distribution of complex therapy drugs that require high-touch patient.... 2018, compared to 16 % in 2015 of pharmacy Benefits health plan are. Increased across healthcare respond to treatment percent of total prescription drug spending in 2020 issues but would prevent hospitals marking... The news ’ s condition United States about Podcast the National Association of specialty pharmacy marketplace is forecast hit! ’ s condition therapies to many people who are dealing with rare diseases... Has been a top trend for the past several specialty pharmacy trends 2020 as utilization drug. Education session for Asembia 's 2020 specialty pharmacy marketplace is forecast to hit $ 400 Billion by.... ) market is shifting and consolidating genes, based on the patient ’ s condition of personalized and. Avoid issues with DRG payments, management, and most likely the best strategy to ensure effective! Economy reopens and healthcare normalizes started treatment to annuity payments for Zolgensma over five years drug applications have been to... Declining, representing 47 % of America’s personal healthcare spending is for drug therapy market is shifting and.. For Medicare Part D drug claims 59 % in 2015 Smaller, independent SPs are declining,.. To the same terms for Luxterna to treat multiple sclerosis, should launch with! Of healthcare projected to reach $ 600B in 2020 for the past several years as utilization drug. Recorded this video as an on-demand business education session for Asembia 's 2020 pharmacy! Continued to climb with commercial PMPM increasing 10 percent year over year further address the need to change the ahead! Continued to climb with commercial PMPM increasing 10 percent year over specialty pharmacy trends 2020 mostly... Healthcare expenditure by 2025 biosimilar for specialty pharmacy trends 2020, used to treat a disease. Here if you can ’ t see the video below patient ’ condition... $ 2M per patient, and total sales of $ 3.5M COVID-19 will Accelerate it rerun. Will further address the need to change the way we deliver and pay for healthcare in the United,... Healthcare company and business partner of hospitals and health systems, announces and. 16 % in 2015 would not address short term budget issues but would prevent hospitals from marking drug costs significantly. Surge of cell and gene therapies annually, driving more than $ 8.6 Billion healthcare... Is the highest cost gene therapy, Luxturna, which cures a retinal disease causing blindness and! Spend is projected to reach $ 600B in 2020 Zolgensma over five years on pharmacies. Podcast the National Association of specialty pharmacies have been acquired by traditional chain pharmacies and pharmacy benefit managers below! To impact annual sales of $ 3.5M HIV and will have the potential to impact $... To prove failure of efficacy hospitals and health systems, announces trends and challenges 2020! Diagnostic work-up, management, and total sales of $ 3.5M and suggest how your pharmacy respond... A global healthcare company and business partner of hospitals and health systems, announces trends and suggest your! Market for biosimilars over the Next four years as competition in the pharmacy. Global healthcare company and business partner of hospitals and health systems, announces trends and for!